|
MYCBP expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.295800E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.127400E-01 |
| Normal-vs-Stage2 |
7.431600E-01 |
| Normal-vs-Stage3 |
1.956180E-02 |
| Normal-vs-Stage4 |
5.121200E-01 |
| Stage1-vs-Stage2 |
5.545000E-01 |
| Stage1-vs-Stage3 |
1.379600E-01 |
| Stage1-vs-Stage4 |
8.991600E-01 |
| Stage2-vs-Stage3 |
1.505570E-01 |
| Stage2-vs-Stage4 |
8.123000E-01 |
| Stage3-vs-Stage4 |
3.345200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.103800E-01 |
| Normal-vs-AfricanAmerican |
1.083970E-01 |
| Normal-vs-Asian |
5.287600E-02 |
| Caucasian-vs-AfricanAmerican |
4.296400E-01 |
| Caucasian-vs-Asian |
2.618200E-01 |
| AfricanAmerican-vs-Asian |
3.531400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.763420E-01 |
| Normal-vs-Female |
4.030600E-01 |
| Male-vs-Female |
5.021600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.546200E-02 |
| Normal-vs-Extreme_Weight |
2.464400E-01 |
| Normal-vs-Obese |
3.541600E-01 |
| Normal-vs-Extreme_Obese |
1.008630E-01 |
| Normal_Weight-vs-Extreme_Weight |
4.097400E-01 |
| Normal_Weight-vs-Obese |
2.949000E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.465400E-01 |
| Extreme_Weight-vs-Obese |
7.399800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.080800E-01 |
| Obese-vs-Extreme_Obese |
4.268000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.257200E-01 |
| Normal-vs-Age(41-60Yrs) |
3.949600E-01 |
| Normal-vs-Age(61-80Yrs) |
1.280820E-01 |
| Normal-vs-Age(81-100Yrs) |
7.056500E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.401600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.565600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.220230E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.251000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.816400E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.342840E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
8.582200E-01 |
| Normal-VS-Type2 PRCC |
8.778700E-04 |
| Normal-VS-KIRP CIMP |
3.641000E-01 |
| Normal-VS-Unclassified PRCC |
4.224200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
7.68439999965231E-07 |
| Type1 PRCC-VS-KIRP CIMP |
4.370000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
3.690200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.916380E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.130300E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
8.540400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.398300E-03 |
| Normal-vs-N1 |
1.459650E-01 |
| Normal-vs-N2 |
8.584800E-01 |
| N0-vs-N1 |
4.686200E-01 |
| N0-vs-N2 |
2.195400E-01 |
| N1-vs-N2 |
4.421200E-01 |
|
|
